Loading organizations...
Key people at Forge Life Science Partners.
Forge Life Science Partners is an investment and partnership organization focused on collaborating with life science entrepreneurs, founders, and operators to develop the next generation of groundbreaking therapeutics. Operating primarily within the broader biotechnology and pharmaceutical sectors, the firm specifically targets early-stage and clinical-stage therapeutic development initiatives that address significant unmet medical needs globally. By providing strategic support and operational resources, the entity aims to accelerate the progression of novel medical treatments from initial scientific discovery through the complex regulatory and commercialization processes. At this present time, specific operational metrics regarding total assets under management, portfolio company valuations, employee headcount, and lead institutional investors remain undisclosed in major public financial reporting databases. Furthermore, the exact founding year and the specific identities of the original founders have not yet been publicly released by the organization.
Key people at Forge Life Science Partners.
Forge Life Science Partners has 2 tracked investments across 2 companies. The latest tracked deal is $100.0M Series A in OnCusp Therapeutics in January 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | OnCusp Therapeutics | $100.0M Series A | Novo Ventures, OrbiMed, Chong XU | F Prime Capital, Blackbird BioVentures, Catalio Capital, Marshall Wace, Sofinnova Investments |
| Nov 1, 2022 | Escient Pharmaceuticals | $120.0M Series C | Abingworth, Forge Life Science Partners, NEA | 5AM Ventures, Access Biotechnology, Atlas Venture, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, Sanofi Ventures, The Column Group, Altitude Life Science Ventures, Avego Bioscience Capital, Cowen Healthcare Investments, PFM Health Sciences, Redmile Group, The Eleven Fund |